[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

October 2019 | 513 pages | ID: B5D7F645DFBEN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019' provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Bone Grafts and Substitutes Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
3.2 Bone Grafts and Substitutes - Pipeline Products by Segment
3.3 Bone Grafts and Substitutes - Pipeline Products by Territory
3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials

4 BONE GRAFTS AND SUBSTITUTES - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development

5 BONE GRAFTS AND SUBSTITUTES COMPANIES AND PRODUCT OVERVIEW

5.1 Adocia SAS Company Overview
5.2 Aesculap Biologics LLC Company Overview
5.3 Agenta Biotechnologies Inc (Inactive) Company Overview
5.4 Alphatec Holdings Inc Company Overview
5.5 Amend Surgical, Inc. Company Overview
5.6 Anika Therapeutics Inc Company Overview
5.7 Antibe Therapeutics Inc Company Overview
5.8 Aperion Biologics Corp Company Overview
5.9 Arthro Kinetics AG Company Overview
5.10 Aursos, Inc (Inactive) Company Overview
5.11 Baxter International Inc Company Overview
5.12 Berkeley Advanced Biomaterials Inc Company Overview
5.13 Bio2 Technologies Inc Company Overview
5.14 Bioactive Bone Substitutes Plc Company Overview
5.15 BioGend Therapeutics Co Ltd Company Overview
5.16 BiolMed Innovations Pvt Ltd Company Overview
5.17 Biomatlante SA Company Overview
5.18 Bioregeneration Technologies, Inc Company Overview
5.19 Biorez Inc Company Overview
5.20 Bio-Scaffold International Pte Ltd Company Overview
5.21 Bioventus LLC Company Overview
5.22 Bone Solutions Inc Company Overview
5.23 BoneGrafix, Inc. Company Overview
5.24 BoneSupport AB Company Overview
5.25 Bonus BioGroup Ltd Company Overview
5.26 Calcitec, Inc. Company Overview
5.27 Carmell Therapeutics Corp Company Overview
5.28 Case Western Reserve University Company Overview
5.29 CeraPedics Inc Company Overview
5.30 Citrics Biomedical, LLC (Inactive) Company Overview
5.31 Collagen Solutions Plc Company Overview
5.32 Collplant Biotechnologies Ltd Company Overview
5.33 ConMed Corp Company Overview
5.34 curasan AG Company Overview
5.35 Daewoong Pharmaceutical Co Ltd Company Overview
5.36 Dimension Inx LLC Company Overview
5.37 Drexel University Company Overview
5.38 DSM Biomedical BV Company Overview
5.39 Element Orthopedics Inc (Inactive) Company Overview
5.40 ElutInc Company Overview
5.41 Ember Therapeutics Inc (Inactive) Company Overview
5.42 EpiBone Inc Company Overview
5.43 Eskisehir Osmangazi University Company Overview
5.44 EternoGen Aesthetics LLC Company Overview
5.45 Exactech Inc Company Overview
5.46 Ferring Pharmaceuticals AS Company Overview
5.47 Gene Biotherapeutics Inc Company Overview
5.48 Graftoss Limited Company Overview
5.49 Graftys SA Company Overview
5.50 Hospital for Special Surgery Company Overview
5.51 Induce Biologics Inc. Company Overview
5.52 Innovoss Inc. (Inactive) Company Overview
5.53 IRCCS San Raffaele Hospital Company Overview
5.54 Isto Biologics Company Overview
5.55 Johns Hopkins University Company Overview
5.56 kasios sas Company Overview
5.57 King's College London Company Overview
5.58 Kuros Biosciences AG Company Overview
5.59 Kytogenics Pharmaceuticals Inc Company Overview
5.60 Lattice Biologics Ltd Company Overview
5.61 Locate Bio Ltd Company Overview
5.62 Maxigen Biotech Inc Company Overview
5.63 Medisse BV (Inactive) Company Overview
5.64 Medtronic plc Company Overview
5.65 Miromatrix Medical Inc Company Overview
5.66 N2 Biomedical Company Overview
5.67 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
5.68 National University of Science and Technology MiSiS Company Overview
5.69 NovaBone Products LLC Company Overview
5.70 Nutech Medical Inc Company Overview
5.71 Oligo Medic Inc Company Overview
5.72 Orthocell Ltd Company Overview
5.73 OrthoMedex LLC Company Overview
5.74 OrthoPediatrics Corp Company Overview
5.75 Orthosera GmbH Company Overview
5.76 Osiris Therapeutics Inc Company Overview
5.77 OssiFi, Inc. Company Overview
5.78 OsteoNovus, LLC Company Overview
5.79 PolyPid Ltd Company Overview
5.80 Polytechnic University of Catalonia Company Overview
5.81 Promimic AB Company Overview
5.82 ReCaPP Company Overview
5.83 RepRegen Ltd. (Inactive) Company Overview
5.84 Revivicor Inc Company Overview
5.85 RTI Surgical Inc Company Overview
5.86 Sanara MedTech Inc Company Overview
5.87 Scil Technology GmbH Company Overview
5.88 SeaSpine, Inc. Company Overview
5.89 SIRAKOSS Ltd Company Overview
5.90 Sofregen Medical Inc Company Overview
5.91 Soteira Inc Company Overview
5.92 SurgaColl Technologies Ltd Company Overview
5.93 T&R Biofab Co Ltd Company Overview
5.94 TBF Genie Tissulaire Company Overview
5.95 The Chinese University of Hong Kong Company Overview
5.96 Theragnostic Technologies Inc Company Overview
5.97 Tissue Regeneration Systems, Inc. Company Overview
5.98 Trinity College Dublin Company Overview
5.99 University of California San Diego Company Overview
5.100 University of Edinburgh Company Overview
5.101 University of Malaya Company Overview
5.102 University of Maryland Company Overview
5.103 University of Memphis Company Overview
5.104 University of Pecs Company Overview
5.105 University of South Florida Company Overview
5.106 Vanderbilt University Company Overview
5.107 Wayne State University Company Overview
5.108 Wright Medical Group NV Company Overview
5.109 Xtant Medical Holdings Inc Company Overview

6 BONE GRAFTS AND SUBSTITUTES- RECENT DEVELOPMENTS

6.1 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
6.2 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
6.3 Sep 24, 2019: Kuros Biosciences announces full commercial launch of MagnetOs and exhibitor status at North American Spine Society 34th Annual Meeting
6.4 Sep 24, 2019: Bone Bank Allografts launches global sales force initiative
6.5 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors
6.6 Sep 19, 2019: Medicrea reports first half 2019 financial results
6.7 Sep 04, 2019: Biogennix Launches Agilon Bone Grafting Solution
6.8 Aug 30, 2019: Bone Therapeutics reports half year 2019 results
6.9 Aug 30, 2019: BBS Interim Report H1/2019
6.10 Aug 29, 2019: Lattice Biologics reports third quarter 2019 results
6.11 Aug 28, 2019: BONESUPPORT announces partnership with Academy Medical
6.12 Aug 28, 2019: Medtronic announces planned leadership succession
6.13 Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit
6.14 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly
6.15 Aug 21, 2019: BONESUPPORT HOLDING announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
6.16 Aug 21, 2019: NuVasive: Departure of directors or certain officers
6.17 Aug 20, 2019: Kuros Biosciences reports results for first half 2019
6.18 Aug 20, 2019: Medtronic reports first quarter financial results for 2019

7.APPENDIX

LIST OF TABLES

Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment
Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory
Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials
Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
Table 9: Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 10: BioChaperone BMP - Degenerative Disc Disease - Product Status
Table 11: BioChaperone BMP - Degenerative Disc Disease - Product Description
Table 12: Biochaperone BMP - Non-Union Fractures - Product Status
Table 13: Biochaperone BMP - Non-Union Fractures - Product Description
Table 14: BioChaperone BMP - Osteoporosis - Product Status
Table 15: BioChaperone BMP - Osteoporosis - Product Description
Table 16: Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 17: NOVOCART DISC - Product Status
Table 18: NOVOCART DISC - Product Description
Table 19: Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 20: B-247 Cranial Bone Graft Implant - Product Status
Table 21: B-247 Cranial Bone Graft Implant - Product Description
Table 22: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Alphatec Neocore Osteoconductive Matrix - Product Status
Table 24: Alphatec Neocore Osteoconductive Matrix - Product Description
Table 25: Bonex - Product Status
Table 26: Bonex - Product Description
Table 27: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Biomimetic Bone - Product Status
Table 29: Biomimetic Bone - Product Description
Table 30: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Hyalobone - Product Status
Table 32: Hyalobone - Product Description
Table 33: Hyalofast - Product Status
Table 34: Hyalofast - Product Description
Table 35: Hyalograft C Autograft - Product Status
Table 36: Hyalograft C Autograft - Product Description
Table 37: Anika Therapeutics Inc - Ongoing Clinical Trials Overview
Table 38: Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control
Table 39: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: CGX-227 - Product Status
Table 41: CGX-227 - Product Description
Table 42: CGX-443 - Product Status
Table 43: CGX-443 - Product Description
Table 44: Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Z-Fix - Product Status
Table 46: Z-Fix - Product Description
Table 47: Z-Meniscus - Product Status
Table 48: Z-Meniscus - Product Description
Table 49: Z-Patch - Product Status
Table 50: Z-Patch - Product Description
Table 51: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
Table 52: CaReS plus - Product Status
Table 53: CaReS plus - Product Description
Table 54: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 55: AUR-84 Resorbable Implant - Product Status
Table 56: AUR-84 Resorbable Implant - Product Description
Table 57: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Synthetic Bone Graft - Spinal - Product Status
Table 59: Synthetic Bone Graft - Spinal - Product Description
Table 60: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: CPA Ceramics - Product Status
Table 62: CPA Ceramics - Product Description
Table 63: HAP Ceramics - Product Status
Table 64: HAP Ceramics - Product Description
Table 65: Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Vitrium - Hammertoe Correction - Product Status
Table 67: Vitrium - Hammertoe Correction - Product Description
Table 68: Vitrium - Radial Osteotomy - Product Status
Table 69: Vitrium - Radial Osteotomy - Product Description
Table 70: Vitrium - Wrist Fracture Revision - Product Status
Table 71: Vitrium - Wrist Fracture Revision - Product Description
Table 72: Bioactive Bone Substitutes Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: ARTEBONE - Product Status
Table 74: ARTEBONE - Product Description
Table 75: Bone Graft Substitute - Blocks - Product Status
Table 76: Bone Graft Substitute - Blocks - Product Description
Table 77: Bone Graft Substitute - Granules - Product Status
Table 78: Bone Graft Substitute - Granules - Product Description
Table 79: BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 80: OIF - Non-Union Bone Fracture - Product Status

LIST OF FIGURES

Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development
Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment
Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory
Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials

COMPANIES MENTIONED

Adocia SAS
Aesculap Biologics LLC
Agenta Biotechnologies Inc (Inactive)
Alphatec Holdings Inc
Amend Surgical, Inc.
Anika Therapeutics Inc
Antibe Therapeutics Inc
Aperion Biologics Corp
Arthro Kinetics AG
Aursos, Inc (Inactive)
Baxter International Inc
Berkeley Advanced Biomaterials Inc
Bio2 Technologies Inc
Bioactive Bone Substitutes Plc
BioGend Therapeutics Co Ltd
BiolMed Innovations Pvt Ltd
Biomatlante SA
Bioregeneration Technologies, Inc
Biorez Inc
Bio-Scaffold International Pte Ltd
Bioventus LLC
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Bonus BioGroup Ltd
Calcitec, Inc.
Carmell Therapeutics Corp
Case Western Reserve University
CeraPedics Inc
Citrics Biomedical, LLC (Inactive)
Collagen Solutions Plc
Collplant Biotechnologies Ltd
ConMed Corp
curasan AG
Daewoong Pharmaceutical Co Ltd
Dimension Inx LLC
Drexel University
DSM Biomedical BV
Element Orthopedics Inc (Inactive)
ElutInc
Ember Therapeutics Inc (Inactive)
EpiBone Inc
Eskisehir Osmangazi University
EternoGen Aesthetics LLC
Exactech Inc
Ferring Pharmaceuticals AS
Gene Biotherapeutics Inc
Graftoss Limited
Graftys SA
Hospital for Special Surgery
Induce Biologics Inc.
Innovoss Inc. (Inactive)
IRCCS San Raffaele Hospital
Isto Biologics
Johns Hopkins University
kasios sas
King's College London
Kuros Biosciences AG
Kytogenics Pharmaceuticals Inc
Lattice Biologics Ltd
Locate Bio Ltd
Maxigen Biotech Inc
Medisse BV (Inactive)
Medtronic plc
Miromatrix Medical Inc
N2 Biomedical
National Center of Innovation for Biomaterials in Orthopaedic Research
National University of Science and Technology MiSiS
NovaBone Products LLC
Nutech Medical Inc
Oligo Medic Inc
Orthocell Ltd
OrthoMedex LLC
OrthoPediatrics Corp
Orthosera GmbH
Osiris Therapeutics Inc
OssiFi, Inc.
OsteoNovus, LLC
PolyPid Ltd
Polytechnic University of Catalonia
Promimic AB
ReCaPP
RepRegen Ltd. (Inactive)
Revivicor Inc
RTI Surgical Inc
Sanara MedTech Inc
Scil Technology GmbH
SeaSpine, Inc.
SIRAKOSS Ltd
Sofregen Medical Inc
Soteira Inc
SurgaColl Technologies Ltd
T&R Biofab Co Ltd
TBF Genie Tissulaire
The Chinese University of Hong Kong
Theragnostic Technologies Inc
Tissue Regeneration Systems, Inc.
Trinity College Dublin
University of California San Diego
University of Edinburgh
University of Malaya
University of Maryland
University of Memphis
University of Pecs
University of South Florida
Vanderbilt University
Wayne State University
Wright Medical Group NV
Xtant Medical Holdings Inc


More Publications